FDA Issues Warning of Cancer Risk Tied to CAR-T Therapies

Key points:

• The U.S. Food and Drug Administration (FDA) has issued a warning about a potential cancer risk associated with CAR-T cell therapies.
• CAR-T cell therapies are a type of immunotherapy that uses a patient’s own immune cells to fight cancer.
• The FDA has identified an increased risk of developing a type of cancer called B-cell lymphoma following treatment with CAR-T cell therapies.
• The warning is based on a review of clinical trials and post-marketing data.
• The FDA is advising healthcare professionals to monitor patients for signs of B-cell lymphoma and to consider alternative treatments if necessary.

Hot take:

Well, it seems like even our immune cells are not immune to the risk of cancer! The FDA has issued a warning about CAR-T cell therapies, giving us a heads-up about the possibility of developing B-cell lymphoma. It’s good to see that the FDA is keeping an eye on the latest medical advancements and ensuring our safety. Remember, folks, always be cautious, even when it comes to cutting-edge treatments.

Original article:https://www.nytimes.com/2024/01/23/health/fda-cancer-car-t-warning.html